Human medicines European public assessment report (EPAR): Klisyri, tirbanibulin, Date of authorisation: 16/07/2021, Revision: 4, Status: Authorised

Assessment templates and guidance

Development of the Clinical Trials Information System

Clinical Trials Regulation: progress on implementation

Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Date of authorisation: 27/03/2013, Revision: 27, Status: Authorised

Biltricide

Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion

Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Tyverb, lapatinib, Date of authorisation: 10/06/2008, Revision: 38, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – July 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 July 2025, 10:00 (CEST) to 23 July 2025, 11:30 (CEST)